Company
Adastra Holdings Ltd. (XTXXF)
Standardized SEC financial data for Adastra Holdings Ltd. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001891512 · OTC · Pharmaceutical Preparations.
Gross margin
46.0%
Net margin
-32.2%
Revenue growth (YoY)
165.7%
Return on equity
-23.5%
Ratios for fiscal year 2022, standardized from SEC filings.
Income statement
| C$ | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Revenue | C$2.5M | C$5.6M | C$15.6M |
| Cost of revenue | C$1.7M | C$3.7M | C$7.2M |
| Gross profit | C$786K | C$1.9M |
Balance sheet
| C$ | FY2019 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Goodwill | — | C$0 | C$0 | C$11.1M | C$9.4M |
| Total assets | — | — |
Get XTXXF data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/XTXXF/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/XTXXF/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"